Connect with us

Hi, what are you looking for?

Law

Dallas Non-Compete Attorney Keith Clouse: Dallas Court of Appeals Rules for Physicians in Dispute with Employer

/cdklawyers.com// 07/21/2010

Dallas non-compete lawyer Keith Clouse notes that the Dallas Court of Appeals recently affirmed summary judgment for a group of physicians against their employer.  Greenville Surgery Center, Ltd. v. Beebe, No. 05-08-01045-CV (Tex. App.—Dallas July 9, 2010), available at http://www.5thcoa.courts.state.tx.us/cgi-bin/as_web.exe?c05topin.ask+D+59681.

GSC owns an ophthalmology surgery center. A group of doctors invested in GSC as limited partners.  The limited partnership agreement contained a covenant not to compete forbidding the doctors from competing with GSC for two years post-termination.  In 2008, nine limited partners planned to open a new facility and filed suit, seeking a declaration that the covenant not to compete was unenforceable.  GSC counterclaimed for breach of contract.  The trial court granted summary judgment for the doctors.

Under the Texas non-compete statute, a covenant not to compete cannot be enforced against a person licensed as a physician unless it contains a buy-out provision.  Here, the covenant contained no buy-out provision, and, therefore, it was unenforceable against the doctors.  The Court thus affirmed the judgment of the trial court.

Keith Clouse litigates non-compete issues on behalf of physicians.  To speak to Mr. Clouse about a non-compete agreement, contact the employment lawyers at Clouse Dunn Khoshbin LLP at info@cdklawyers.com

Press Release Contact Information:

KEITH A. CLOUSE

Clouse Dunn
Khoshbin LLP

214.220.2722
214.220.3833 ( fax)
keith@cdklawyers.com

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...